| 产品详情 |
| Edit |   |
|---|
| Product Name | CCL22, Recombinant, Human |
|---|
| Description | Purity 95% (SDS-PAGE). CCL22 (monocyte-derived chemokine) was described initially as a constitutively produced, thymus-specific chemokine, implicated in the recruitment of T cells. One of the functions of CCL22 originally described was induction of migration of CCR4+ Th2 cells, but it has additionally been shown to regulate migration of Tregs. CCL22 has been implicated in a number of diseases, including allergen-induced lung inflammation, atopic dermatitis, and lymphoma. Similarly, a presumed role for CCR4+ cells has been suggested for endotoxic shock, rheumatoid arthritis, T cell lymphoma, and autoimmune diabetes. Source: Recombinant protein corresponding to human CCL22 expressed in E. coli. Molecular Weight: ~8kD Biological Activity: The ED50 was determined by the dose-dependent proliferation of MGC823 cells and was <5ng/mL. Endotoxin: <1EU/ug (LAL) |
|---|
| Size | 20ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | CCL22, Recombinant, Human (STCP-1, ABCD-1, CC Chemokine STCP-1, MDC(1-69), SCYA22, Small-Inducible Cytokine A22, Stimulated T-Cell Chemotactic Protein 1, MDC, C-C Motif Chemokine 22, Macrophage-Derived Chemokine) |
|---|
| Gene, Accession, CAS # | SwissProt: O00626 |
|---|
| Catalog # | 499855 |
|---|
| Price | |
|---|
| Order / More Info | CCL22, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|